Cornercap Investment Counsel Inc Black Diamond Therapeutics, Inc. Transaction History

Cornercap Investment Counsel Inc

  • $302 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$4.2 - $6.58 $107,213 - $167,967
-25,527 Reduced 53.06%
22,583 $98,000
Q2 2024

Aug 08, 2024
SELL
$4.65 - $7.39 $2,413 - $3,835
-519 Reduced 1.07%
48,110 $224,000
Q1 2024

May 10, 2024
SELL
$2.67 - $5.74 $91,193 - $196,049
-34,155 Reduced 41.26%
48,629 $246,000
Q4 2023

Jan 30, 2024
BUY
$1.77 - $3.03 $146,527 - $250,835
82,784 New
82,784 $232,000

Others Institutions Holding BDTX

# of Institutions
94
Shares Held
47.6M
Call Options Held
2.9K
Put Options Held
69.4K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $78.5M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email